Drugs / Intravitreal bevacizumab
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02663141 Background | Jun 2015 → Jun 2016 | diabetic macular edema | Tehran University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intravitreal bevacizumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02663141 ↗ |
| Route | Intravitreal | “Intravitreal bevacizumab” NCT02663141 ↗ |